Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.

Autoantibody to a Nuclear Antigen in Proliferating Cells

1978 • 881 citations

Proliferating cell nuclear antigen is required for DNA excision repair

1992 • 809 citations

The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.

1993 • 756 citations

Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA) structural conservation and the detection of a nucleolar form

1990 • 736 citations

A method to measure the duration of DNA syntheses and the potential doubling time from a single sample

1985 • 599 citations

New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.

1993 • 380 citations

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry

1988 • 310 citations

A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction

1991 • 285 citations

Ki-67 detects a nuclear matrix-associated proliferation-related antigen: II. Localization in mitotic cells and association with chromosomes

1989 • 263 citations

The cell cycle associated change of the Ki‐67 reactive nuclear antigen expression

1987 • 228 citations

Immunohistochemical markers of cellular proliferation: achievements, problems and prospects

1990 • 207 citations

The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry

1985 • 202 citations

Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851

1992 • 187 citations

The relevance of antibody concentration to the immunohistological quantification of cell proliferation‐associated antigens

1993 • 146 citations

Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications

1993 • 129 citations

Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck

1992 • 128 citations

The proliferation‐associated Ki‐67 protein: definition in molecular terms

1994 • 88 citations

In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.

1995 • 85 citations

Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo

1994 • 83 citations

Assessment of Human Tumour Proliferation Using Bromodeoxyuridine—Current Status

1991 • 79 citations

A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.

1993 • 74 citations

Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy

1995 • 63 citations

In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy

1993 • 48 citations

Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?

1994 • 47 citations

Immunofluorescent quantification of ribonucleotide reductase M1 subunit and correlation with DNA content by flow cytometry

1987 • 42 citations

Polymorphous sweat gland carcinoma

1994 • 24 citations

Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase α

1990 • 17 citations

Cell kinetics to monitor radioresponsivity in human epidermoid carcinoma.

1986 • 8 citations